Pure Global
NCT06380894

Virtual Reality Cognitive Training for Mild Cognitive Impairment

Virtual Reality Cognitive Training for Mild Cognitive Impairment - A Pilot Feasibility Study
Changi General Hospital·ClinicalTrials.gov·device·Device trialCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Mild Cognitive Impairment
Drug/Device/Intervention
Virtual Reality Cognitive Training
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Changi General Hospital
Location
Singapore, Singapore
Timeline & enrollment
Phase
N/A
Start date
Jan 27, 2021
End date
Jan 31, 2023
Enrollment
20 participants
Primary outcome

Change from Baseline in Memory Performance on the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) subtests at Week 11,Change from Baseline in Attention Performance on the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) subtest at Week 11,Change from Baseline in Attention Performance on the Colour Trails Test 1 at Week 11,Change from Baseline in Executive Function Performance on the Frontal Assessment Battery (FAB) at Week 11,Change from Baseline in Executive Function Performance on the Colour Trails Test 2 at Week 11

Summary

This study aims to assess the feasibility and efficacy of a 10-weekly multi-domain VRCT
 program on the cognitive function (i.e. attention, memory, and executive functioning) of
 older adults with MCI.

ICD-10 classifications
Mild cognitive disorderAlzheimer diseaseDementia in other specified diseases classified elsewhereDementia in other diseases classified elsewhereDementia in Alzheimer disease
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06380894
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06380894 through Pure Global AI's free database. This phase not specified trial is sponsored by Changi General Hospital and is currently Completed. The study focuses on Mild Cognitive Impairment. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.